Results 41 to 50 of about 54,240 (219)

Non-ST-segment elevation acute coronary syndromes: an algorithm for decision [PDF]

open access: yesEuropean Heart Journal, 2007
We have read with great interest the report1 of the Task Force concerning the guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes (NST-ACS). We would like to compliment the Task Force members for this excellent work, updating the previous ESC guidelines concerning that matter.
Michel E, Bertrand   +2 more
openaire   +2 more sources

What's the Risk? Older Women Report Fewer Symptoms for Suspected Acute Coronary Syndrome than Younger Women. [PDF]

open access: yes, 2018
The purpose of the study was to determine whether older (≥65 years) and younger (<65 years) women presenting to the emergency department (ED) with symptoms suggestive of acute coronary syndrome (ACS) varied on risk factors, comorbid conditions ...
Breen, Katherine   +6 more
core   +2 more sources

Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease [PDF]

open access: yes, 2019
The diagnosis of acute coronary syndromes (ACS) is heavily dependent on cardiac biomarker assays, particularly cardiac troponins. ACS, particularly non-ST segment elevation MI, are more common in patients with acute kidney injury, chronic kidney disease (
Banerjee, A, Banerjee, D, Ferrett, C
core   +2 more sources

Sudden Cardiac Death After Non–ST-Segment Elevation Acute Coronary Syndrome [PDF]

open access: yesJAMA Cardiology, 2016
In the current therapeutic era, the risk for sudden cardiac death (SCD) after non-ST-segment elevation acute coronary syndrome (NSTE ACS) has not been characterized completely.To determine the cumulative incidence of SCD during long-term follow-up after NSTE ACS, to develop a risk model and risk score for SCD after NSTE ACS, and to assess the ...
Paul L, Hess   +17 more
openaire   +2 more sources

Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)

open access: yesРоссийский кардиологический журнал, 2019
The conclusion of the Expert Council reports an agreement on the place of the P2Y12 receptor blocker prasugrel in the early invasive treatment of patients with acute coronary syndrome ACS, according to the results of the multicenter randomized controlled
S. N. Tereshchenko   +24 more
doaj   +1 more source

GAMBARAN HEMATOLOGI PADA PASIEN ACUTE CORONARY SYNDROME DI RUMAH SAKIT UMUM DAERAH DR. ZAINOEL ABIDIN BANDA ACEH [PDF]

open access: yes, 2017
Acute Coronary Syndrome (ACS) merupakan salah satu masalah utama dalam penyakit kardiovaskular, karena dapat menyebabkan peningkatan angka perawatan rumah sakit dan angka kematian.
MEIDI SEPTIANA
core  

Systematic review and meta-analysis of optimal P2Y₁₂ blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome [PDF]

open access: yes, 2016
Background: Patients with diabetes are at increased risk of acute coronary syndromes (ACS) and their mortality and morbidity outcomes are significantly worse following ACS events, independent of other comorbidities.
Brown, Oliver I   +2 more
core   +1 more source

Adipocytes in Aortic Stenosis: Association With Clinical and Morphological Indices

open access: yesClinical Anatomy, EarlyView.
ABSTRACT Recently, great attention has been given to understanding the new pathogenetic mechanisms underlying aortic stenosis (AS). The study aims to understand the role of mature adipocytes in AS and their association with histologic, clinical, and echocardiographic data, an area previously overlooked in AS research.
Elena Zoico   +9 more
wiley   +1 more source

Serum Concentrations of Matrix Metalloproteinase‐1 and Procollagen Type I Carboxy Terminal Propeptide Discriminate Infarct‐Like Myocarditis and Non−ST‐Segment−Elevation Myocardial Infarction

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Biomarkers simplifying the diagnostic workup by discriminating between non–ST‐segment–elevation myocardial infarction (NSTEMI) and infarct‐like myocarditis are an unmet clinical need.
Lucas Bacmeister   +18 more
doaj   +1 more source

Acute coronary syndrome: analysis of two case reports

open access: yesClinical Management Issues, 2009
The patients presenting acute coronary syndrome without ST segment elevation can have a short and long-term risk of death or recurrent ischemic events. Therefore, the evaluation of risk is an essential step in the management of such patients.
Marco Mascellanti
doaj   +1 more source

Home - About - Disclaimer - Privacy